Oric Pharmaceuticals Inc (ORIC) Hedge Fund & Institutional Holdings (Q2 2026)

ORIC ranks #3275 out of 37696 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

ORIC is a top-conviction position for Column Group LLC — at 43.5% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

The largest dollar stake in ORIC belongs to Nextech Invest Ltd., but the position matters far more to Column Group LLC, who has 43.5% of their own portfolio riding on it — a reminder that the biggest holder by size and the holder with the biggest bet aren't always the same fund.

Wealth Enhancement Advisory Services, LLC has added to its ORIC position for two straight quarters, increasing it by $153.3K to reach $257.8K today.

ORIC is down 3.3% today, but institutions show net buying of $130.7M this quarter — a divergence between today's price move and the underlying institutional flow.

ORIC reported a net loss of $129.5M in its latest fiscal year.

• Not yet profitable — net loss of $129.5M in the latest fiscal year
• Net income declined year over year, from -$127.8M to -$129.5M
• Operating cash flow was negative, using $111.0M in cash
• Current ratio of 14.13x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.06x equity — within a conventional range